Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
     L04A IMMUNOSUPPRESSANTS
       L04AA Selective immunosuppressants
       L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
       L04AC Interleukin inhibitors
         L04AC01 Daclizumab
         L04AC02 Basiliximab
         L04AC03 Anakinra
         L04AC04 Rilonacept
         L04AC05 Ustekinumab
         L04AC07 Tocilizumab
         L04AC08 Canakinumab
         L04AC09 Briakinumab
         L04AC10 Secukinumab
         L04AC11 Siltuximab
         L04AC12 Brodalumab
         L04AC13 Ixekizumab
           D10071  Ixekizumab (USAN) <JP/US>
         L04AC14 Sarilumab
         L04AC15 Sirukumab
         L04AC16 Guselkumab
         L04AC17 Tildrakizumab
       L04AD Calcineurin inhibitors
       L04AX Other immunosuppressants
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 4, 2019
According to WHO's ATC 2019

» Japanese version